talvey
janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
tecvayli
janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastična sredstva - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
actair 300 ir podjezične tablete
alergenski izvleček pršic dermatophagoides pteronyssinus in dermatophagoides far - podjezična tableta - alergenski izvleček pršic dermatophagoides pteronyssinus in dermatophagoides far 300 ir / 1 tableta - pršice v hišnem prahu
actair 300 ir podjezične tablete
alergenski izvleček pršic dermatophagoides pteronyssinus in dermatophagoides far - podjezična tableta - alergenski izvleček pršic dermatophagoides pteronyssinus in dermatophagoides far 300 ir / 1 tableta - pršice v hišnem prahu
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
spiriva respimat 2,5 mikrograma raztopina za inhaliranje
boehringer ingelheim international gmbh - tiotropij - raztopina za inhaliranje - tiotropij 2,5 µg / 1 odmerek - tiotropijev bromid
spiriva respimat 2,5 mikrograma raztopina za inhaliranje
tiotropij - raztopina za inhaliranje - tiotropij 2,5 µg / 1 odmerek - tiotropijev bromid